1986
DOI: 10.1016/0277-5379(86)90138-0
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Intrahepatic arterial administration of 4′epidoxorubicin (epirubicin) in advanced cancer patients. A pharmacokinetic study

Search citation statements

Order By: Relevance

Paper Sections

Select...
11
0
0
0

Citation Types

0
2
0
0

Year Published

Range
1987
1987
2006
2006

Publication Types

Select...
10
1

Relationship

0
11

Authors

Journals

citations

Cited by 11 publications

(2 citation statements)
references

References 5 publications

0
2
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…After intravenous administration, less than 20% of the injected dose is recovered in urine, either as unchanged drug or as epirubicinol and glucuronide metabolites (Camaggi et al 1988;Mross et al 1988;Robert et al 1985;Vrignaud et al 1985). Cumulative biliary excretion was approximately 40% over a 3-day period (Camaggi et al 1986). In total, 50% of an epirubicin dose is eliminated within 4 days, compared with 7 days for elimination of 50% of a dose of doxorubicin.…”
Section: Distribution and Excretion
mentioning
confidence: 99%
“…Several investigators have studied intrahepatic administration of epirubicin through the hepatic artery (Eksborg et al 1986a;Pannuti et al 1986;Strocchi et al 1985). After intrahepatic administration, systemic drug concentrations were significantly lower than after intravenous administration and the total body clearance of the drug was 1.5-to 2-fold higher.…”
Section: Pharmacokinetic Profile Of Other Routes Of Administration
mentioning
confidence: 99%
See 1 more Smart Citation